However, ANXA1 expression is upregulated in malignant glioma tissues; it is secreted by necrotic glioma cells, and abnormal levels of ANXA1 in the tumour microenvironment can activate formyl peptide receptor 1 to enhance the proliferation and invasion of glioma [20]. The gene discussed is ANXA1; the disease is central nervous system cancer.